Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FY9M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,096
Award facts
- Contract value 100% obligated
- $17,095.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,095.99 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a pharmaceutical treatment for overactive bladder, reflecting the Defense Logistics Agency's role in supplying critical medical commodities to support military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp regularly fulfills competitively awarded delivery orders through this flexible contract mechanism to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY9M1?
SPE2DR26FY9M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FY9M1 worth?
The government has obligated $17,096 on SPE2DR26FY9M1.
Is contract SPE2DR26FY9M1 an order under another contract?
Yes. SPE2DR26FY9M1 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FY9M1 competed?
The extent of competition for SPE2DR26FY9M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award